Synaptogenix Inc (SNPX)

[InTheTrenches]

The main benefits of Orphan Drug Status:

- Marketing exclusivity for 7 years
- Protocol assistance offered by FDA
- Tax credits of 50% of the clinical drug testing cost awarded upon approval
- Research grants—FDA awarded approximately 75 grants in 2013
- Waiver of NDA/BLA application fee—this is a $2.2 million value


http://pharmaceuticalcommerce.com/opinion/common-misconceptions-about-the-orphan-drug-designation/ (see part 7)